Conessine
AlkaPlorer ID: AK000709
Synonym: None
IUPAC Name: dimethyl-[(1R,2S,5S,6S,9R,12S,13R,16S)-6,7,13-trimethyl-7-azoniapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-en-16-yl]azanium
Structure
SMILES: C[C@H]1[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H]([NH+](C)C)CC[C@]5(C)[C@H]4CC[C@]23C[NH+]1C
InChI: InChI=1S/C24H40N2/c1-16-20-8-9-22-19-7-6-17-14-18(25(3)4)10-12-23(17,2)21(19)11-13-24(20,22)15-26(16)5/h6,16,18-22H,7-15H2,1-5H3/p+2/t16-,18-,19+,20+,21-,22-,23-,24-/m0/s1
InChIKey: GPLGAQQQNWMVMM-MYAJQUOBSA-P
Reference
Alkaloids from callus cultures of Holarrhena floribunda
LOTUS: LTS0085117
SuperNatural Ⅲ: SN0111881-13
NPASS: NPC7214
Source
Properties Information
Molecule Weight: 358.61400000000015
TPSA?: 8.88
MolLogP?: 1.975400000000002
Number of H-Donors: 2
Number of H-Acceptors: 0
RingCount: 5
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Bacillus anthracis | Anthrax lethal factor | Potency | 6309.6 | nM | None |
| Cavia porcellus | Histamine H3 receptor | Kd | 281.84 | nM | 10.1021/jm8003625 |
| Chlorocebus sabaeus | Vero C1008 | CC50 | 34700.0 | nM | 10.6019/CHEMBL4651402 |
| Chlorocebus sabaeus | Vero C1008 | pCC50 | 4.46 | None | 10.6019/CHEMBL4651402 |
| Electrophorus electricus | Acetylcholinesterase | Inhibition | 29.95 | % | 10.1016/j.bmc.2012.09.040 |
| Entamoeba histolytica | Entamoeba histolytica | IC50 | 8.97 | ug.mL-1 | 10.1007/s00044-011-9767-1 |
| Equus caballus | Cholinesterase | Inhibition | 45.25 | % | 10.1016/j.bmc.2012.09.040 |
| Homo sapiens | Adhesion G-protein coupled receptor F1 | %Inhib (Mean) | -9.69 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Adhesion G-protein coupled receptor F1 | %Max (Mean) | 3.031 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Alpha-2a adrenergic receptor | %Inhib (Mean) | 17.3 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Alpha-2a adrenergic receptor | Ki | 660.69 | nM | 10.1021/jm8003625 |
| Homo sapiens | Alpha-2a adrenergic receptor | %Max (Mean) | 5.0 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Alpha-2c adrenergic receptor | Ki | 10.47 | nM | 10.1021/jm8003625 |
| Homo sapiens | Alpha-2c adrenergic receptor | Ki | 10.6 | nM | 10.1021/jm8003625 |
| Homo sapiens | Apelin receptor | %Inhib (Mean) | 3.85 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Apelin receptor | %Max (Mean) | 1.224 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Arachidonate 15-lipoxygenase | Potency | 31622.8 | nM | None |
| Homo sapiens | Beta-2 adrenergic receptor | %Inhib (Mean) | -14.4 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Beta-2 adrenergic receptor | %Max (Mean) | -3.12 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Bromodomain-containing protein 4 | Delta TM | -0.98 | C | None |
| Homo sapiens | C5a anaphylatoxin chemotactic receptor | %Inhib (Mean) | -22.67 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | C5a anaphylatoxin chemotactic receptor | %Max (Mean) | -3.908 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Casein kinase I delta | Delta TM | 0.21 | C | None |
| Homo sapiens | C-X3-C chemokine receptor 1 | %Inhib (Mean) | -22.38 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | C-X3-C chemokine receptor 1 | %Max (Mean) | -2.156 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Cyclin-dependent kinase 2 | Delta TM | 0.15 | C | None |
| Homo sapiens | DNA-(apurinic or apyrimidinic site) lyase | Potency | 44668.4 | nM | None |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 21.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 22.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Fragmented Nuclei % | 28.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 53.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 54.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 56.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 62.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 67.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 68.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Healthy Nuclei (%) | 69.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Membrane Permeable-Phenotype Cells (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Membrane Permeable-Phenotype Cells (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Membrane Permeable-Phenotype Cells (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Membrane Permeable-Phenotype Cells (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Membrane Permeable-Phenotype Cells (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitochondria Different-Phenotype Cells (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitochondria Different-Phenotype Cells (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitochondria Different-Phenotype Cells (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitochondria Different-Phenotype Cells (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitochondria Different-Phenotype Cells (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 42.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 46.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 47.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 51.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 55.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 60.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 61.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Mitotic Cells (%) | 66.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 19.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 21.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 23.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Pyknosed Nuclei (%) | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 14985.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 15057.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 15078.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 15171.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 16285.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 16485.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 16657.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Total Cells | 17835.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Tubulin Phenotype Different Cells (%) | 23.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Tubulin Phenotype Different Cells (%) | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Tubulin Phenotype Different Cells (%) | 25.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Tubulin Phenotype Different Cells (%) | 35.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Tubulin Phenotype Different Cells (%) | 40.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Control DMSO Tubulin Phenotype Different Cells (%) | 41.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Growth Rate | 0.11 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | Fibroblast | Growth Rate | 0.18 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | Fibroblast | Growth Rate | 0.35 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | Fibroblast | Growth Rate | 0.49 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | Fibroblast | Growth Rate | 0.52 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 27.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 29.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 34.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 36.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 37.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 40.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 43.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 45.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 47.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 50.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 64.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Apoptotic (%) | 66.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 17.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 20.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 26.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 27.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 28.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 29.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 30.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 33.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Fragmented Nuclei (%) | 37.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 39.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 41.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 45.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 48.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 49.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 60.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 61.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 62.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 67.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 68.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Healthy Nuclei (%) | 73.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Hoechst High Intensity Objects (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Membrane Permeable-Phenotype (%) | 17.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitochondria Different-Phenotype (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 33.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 35.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 50.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 52.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 55.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 56.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 59.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 62.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 63.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 65.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 70.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Mitotic Cells (%) | 72.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 93.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 94.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 95.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 96.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 97.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 98.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Normal (%) | 99.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 11.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 20.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 21.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 22.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 28.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 30.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Pyknosed Nuclei (%) | 32.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 19.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 22.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 25.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 27.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 28.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 32.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 34.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 46.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 51.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 58.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 60.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 61.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 62.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Population Tubulin-Different-Phenotype (%) | 63.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 95.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 101.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 102.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 104.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 106.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 108.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 110.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 121.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 155.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 168.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 174.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 175.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 178.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 189.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast | Total Cell Count | 190.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Fibroblast growth factor receptor 3 | Delta TM | 0.24 | C | None |
| Homo sapiens | Glucagon-like peptide 1 receptor | %Inhib (Mean) | -16.77 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Glucagon-like peptide 1 receptor | %Max (Mean) | 0.22 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Glucose-dependent insulinotropic receptor | %Inhib (Mean) | -6.898 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Glucose-dependent insulinotropic receptor | %Max (Mean) | 1.285 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Glycogen synthase kinase-3 beta | Delta TM | 0.0 | C | None |
| Homo sapiens | G-protein coupled receptor 120 | %Inhib (Mean) | -43.0 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | G-protein coupled receptor 120 | %Max (Mean) | -1.2 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | G-protein coupled receptor 35 | %Inhib (Mean) | -44.94 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | G-protein coupled receptor 35 | %Max (Mean) | 12.31 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | HEK-293T | Control DMSO Fragmented Nuclei % | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Fragmented Nuclei % | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Fragmented Nuclei % | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Fragmented Nuclei % | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Fragmented Nuclei % | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Fragmented Nuclei % | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Healthy Nuclei (%) | 46.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Healthy Nuclei (%) | 61.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Healthy Nuclei (%) | 79.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Healthy Nuclei (%) | 80.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Healthy Nuclei (%) | 81.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Healthy Nuclei (%) | 82.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Membrane Permeable-Phenotype Cells (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Membrane Permeable-Phenotype Cells (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 36.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 41.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 59.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 65.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitochondria Different-Phenotype Cells (%) | 83.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 40.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 51.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 55.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 63.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 66.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 72.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 75.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Mitotic Cells (%) | 77.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 32.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Pyknosed Nuclei (%) | 45.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 22878.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 29842.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 35035.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 45150.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 45535.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 60692.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 68271.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Total Cells | 101135.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Tubulin Phenotype Different Cells (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Tubulin Phenotype Different Cells (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Tubulin Phenotype Different Cells (%) | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Tubulin Phenotype Different Cells (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Tubulin Phenotype Different Cells (%) | 20.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Control DMSO Tubulin Phenotype Different Cells (%) | 22.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Growth Rate | 0.67 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | HEK-293T | Growth Rate | 0.74 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | HEK-293T | Growth Rate | 0.82 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | HEK-293T | Growth Rate | 0.85 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | HEK-293T | Growth Rate | 0.91 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 25.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 26.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 27.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 30.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 35.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 36.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 47.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 48.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 56.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 59.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Apoptotic (%) | 60.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Fragmented Nuclei (%) | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 38.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 50.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 60.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 68.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 77.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 78.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 79.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 80.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 81.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 82.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 83.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Healthy Nuclei (%) | 85.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Hoechst High Intensity Objects (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Membrane Permeable-Phenotype (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Membrane Permeable-Phenotype (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 20.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 22.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 23.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 32.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 34.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 38.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 39.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 43.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 56.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 58.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 61.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 62.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 73.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 78.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitochondria Different-Phenotype (%) | 84.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 40.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 43.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 51.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 52.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 63.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 64.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 65.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 69.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 72.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 73.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Mitotic Cells (%) | 75.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 84.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 86.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 90.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 91.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 93.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 94.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 95.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Normal (%) | 97.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 11.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 29.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 34.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 42.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Pyknosed Nuclei (%) | 58.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 11.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 17.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 22.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 24.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 25.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 26.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 28.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 30.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Population Tubulin-Different-Phenotype (%) | 38.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 239.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 241.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 273.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 295.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 356.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 384.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 400.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 419.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 474.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 484.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 514.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 572.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 618.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 630.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 735.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | HEK-293T | Total Cell Count | 767.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | Histamine H1 receptor | Ki | 10000.0 | nM | 10.1021/jm8003625 |
| Homo sapiens | Histamine H2 receptor | Ki | 10000.0 | nM | 10.1021/jm8003625 |
| Homo sapiens | Histamine H3 receptor | Activity | 45.0 | % | 10.1016/j.bmcl.2017.08.060 |
| Homo sapiens | Histamine H3 receptor | Ki | 3.467 | nM | 10.1021/jm8003625 |
| Homo sapiens | Histamine H3 receptor | Ki | 5.012 | nM | 10.1016/j.bmc.2008.07.071 |
| Homo sapiens | Histamine H3 receptor | Ki | 5.37 | nM | 10.1021/jm8003625 |
| Homo sapiens | Histamine H3 receptor | Ki | 5.37 | nM | 10.1021/jm900480x |
| Homo sapiens | Histamine H3 receptor | pKb | 6.14 | None | 10.1021/jm8003625 |
| Homo sapiens | Histamine H3 receptor | pKb | 7.96 | None | 10.1021/jm8003625 |
| Homo sapiens | Histamine H3 receptor | pKb | 8.08 | None | 10.1021/jm8003625 |
| Homo sapiens | Histamine H4 receptor | Ki | 10000.0 | nM | 10.1021/jm8003625 |
| Homo sapiens | Lipoxin A4 receptor | %Inhib (Mean) | -18.1 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Lipoxin A4 receptor | %Max (Mean) | -2.91 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | MAP kinase ERK2 | Delta TM | 0.35 | C | None |
| Homo sapiens | Peregrin | Delta TM | -3.04 | C | None |
| Homo sapiens | Serine/threonine-protein kinase Aurora-A | Delta TM | 0.08 | C | None |
| Homo sapiens | Solute carrier organic anion transporter family member 1B1 | Inhibition | 100.94 | % | 10.1124/mol.112.084152 |
| Homo sapiens | Solute carrier organic anion transporter family member 1B3 | Inhibition | 111.46 | % | 10.1124/mol.112.084152 |
| Homo sapiens | Sphingosine 1-phosphate receptor Edg-1 | %Inhib (Mean) | -1.6 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Sphingosine 1-phosphate receptor Edg-1 | %Max (Mean) | -3.444 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Thyroid stimulating hormone receptor | Potency | 2511.9 | nM | None |
| Homo sapiens | Transcription intermediary factor 1-alpha | Delta TM | -1.7 | C | None |
| Homo sapiens | Type-1 angiotensin II receptor | %Inhib (Mean) | -1.599 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Type-1 angiotensin II receptor | %Max (Mean) | -2.484 | % | 10.6019/CHEMBL5209801 |
| Homo sapiens | Tyrosine-protein kinase ABL | Delta TM | 0.1 | C | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 16360.1 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 23715.0 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 29855.4 | nM | None |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 17.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 19.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 23.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 26.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Fragmented Nuclei % | 33.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Healthy Nuclei (%) | 56.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Healthy Nuclei (%) | 65.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Healthy Nuclei (%) | 68.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Healthy Nuclei (%) | 71.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Healthy Nuclei (%) | 74.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Healthy Nuclei (%) | 76.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Membrane Permeable-Phenotype Cells (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Membrane Permeable-Phenotype Cells (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Membrane Permeable-Phenotype Cells (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitochondria Different-Phenotype Cells (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitochondria Different-Phenotype Cells (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitochondria Different-Phenotype Cells (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitochondria Different-Phenotype Cells (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Mitotic Cells (%) | 28.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Pyknosed Nuclei (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Pyknosed Nuclei (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Pyknosed Nuclei (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Pyknosed Nuclei (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 8571.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 11828.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 14221.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 20657.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 20807.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 26450.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 31171.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Total Cells | 44507.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Tubulin Phenotype Different Cells (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Tubulin Phenotype Different Cells (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Control DMSO Tubulin Phenotype Different Cells (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Growth Rate | 0.8 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | U2OS | Growth Rate | 0.89 | None | 10.6019/CHEMBL5058564 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 38.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 55.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 58.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 65.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 75.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 80.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 83.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 85.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 86.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 89.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 90.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Apoptotic (%) | 100.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 11.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 17.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 18.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 19.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 20.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 23.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 31.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Fragmented Nuclei (%) | 32.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 57.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 60.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 68.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 70.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 71.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 72.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 73.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 74.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 79.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Healthy Nuclei (%) | 81.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Hoechst High Intensity Objects (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Hoechst High Intensity Objects (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Hoechst High Intensity Objects (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Hoechst High Intensity Objects (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Hoechst High Intensity Objects (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Hoechst High Intensity Objects (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Membrane Permeable-Phenotype (%) | 14.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitochondria Different-Phenotype (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 0.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 15.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 16.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 19.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 20.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 25.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 35.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 41.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 45.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Mitotic Cells (%) | 61.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 93.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 95.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 96.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 97.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 98.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 99.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Normal (%) | 100.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 4.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 8.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 10.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 12.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Pyknosed Nuclei (%) | 13.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 1.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 2.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 3.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 5.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 6.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 7.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Population Tubulin-Different-Phenotype (%) | 9.0 | % | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 81.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 91.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 107.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 124.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 134.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 153.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 175.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 193.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 198.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 227.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 237.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 248.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 265.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 307.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 370.0 | None | 10.6019/CHEMBL5058577 |
| Homo sapiens | U2OS | Total Cell Count | 430.0 | None | 10.6019/CHEMBL5058577 |
| Leishmania amazonensis | Leishmania amazonensis | GI | 97.0 | % | 10.1016/j.bmc.2008.05.074 |
| Plasmodium falciparum | Plasmodium falciparum | IC50 | 1040.0 | nM | 10.1016/j.bmcl.2005.03.021 |
| Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM14847 / LMG 12228 / 1C / PRS 101 / PAO1) | MexAB/OprM | MIC | 0.25 | ug.mL-1 | 10.1021/acs.jmedchem.8b01781 |
| Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM14847 / LMG 12228 / 1C / PRS 101 / PAO1) | MexAB/OprM | MIC | 2.0 | ug.mL-1 | 10.1021/acs.jmedchem.8b01781 |
| Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM14847 / LMG 12228 / 1C / PRS 101 / PAO1) | MexAB/OprM | MIC | 8.0 | ug.mL-1 | 10.1021/acs.jmedchem.8b01781 |
| Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM14847 / LMG 12228 / 1C / PRS 101 / PAO1) | MexAB/OprM | MIC | 32.0 | ug.mL-1 | 10.1021/acs.jmedchem.8b01781 |
| Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM14847 / LMG 12228 / 1C / PRS 101 / PAO1) | MexAB/OprM | MIC | 256.0 | ug.mL-1 | 10.1021/acs.jmedchem.8b01781 |
| Rattus norvegicus | Blood | Drug uptake | 0.102 | ug ml-1 | 10.1021/jm8003625 |
| Rattus norvegicus | Blood | Drug uptake | 0.306 | ug ml-1 | 10.1021/jm8003625 |
| Rattus norvegicus | Blood | Drug uptake | 0.444 | ug ml-1 | 10.1021/jm8003625 |
| Rattus norvegicus | Brain | Drug uptake | 4.14 | ug/g | 10.1021/jm8003625 |
| Rattus norvegicus | Brain | Drug uptake | 6.57 | ug/g | 10.1021/jm8003625 |
| Rattus norvegicus | Brain | Drug uptake | 6.8 | ug/g | 10.1021/jm8003625 |
| Rattus norvegicus | Histamine H3 receptor | Activity | 34.0 | % | 10.1016/j.bmcl.2017.08.060 |
| Rattus norvegicus | Histamine H3 receptor | Ki | 12.3 | nM | 10.1021/jm8003625 |
| Rattus norvegicus | Histamine H3 receptor | Ki | 24.5 | nM | 10.1021/jm8003625 |
| Rattus norvegicus | Histamine H3 receptor | Ki | 24.5 | nM | 10.1021/jm900480x |
| Rattus norvegicus | Histamine H3 receptor | Ki | 24.55 | nM | 10.1021/jm8003625 |
| Rattus norvegicus | Histamine H3 receptor | Ki | 24.55 | nM | 10.1021/jm900480x |
| Rattus norvegicus | Histamine H3 receptor | Ki | 66.0 | nM | 10.1016/j.bmcl.2007.12.059 |
| Rattus norvegicus | Histamine H3 receptor | pKb | 6.99 | None | 10.1021/jm8003625 |
| Rattus norvegicus | Histamine H3 receptor | pKb | nan | None | 10.1021/jm8003625 |
| Rattus norvegicus | Inositol monophosphatase 1 | Potency | 7943.3 | nM | None |
| Rattus norvegicus | Rattus norvegicus | Activity | nan | None | 10.1021/jm8003625 |
| Rattus norvegicus | Rattus norvegicus | Cp | 0.037 | ug ml-1 | 10.1021/jm8003625 |
| Rattus norvegicus | Rattus norvegicus | Cp | 0.089 | ug ml-1 | 10.1021/jm8003625 |
| Rattus norvegicus | Rattus norvegicus | Cp | 0.148 | ug ml-1 | 10.1021/jm8003625 |
| Rattus norvegicus | Rattus norvegicus | Selectivity index | 14.0 | uM | 10.1016/j.bmcl.2005.03.021 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 12000.0 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 12022.64 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 25100.0 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 25118.86 | nM | 10.6019/CHEMBL4651402 |
| Trypanosoma cruzi | Trypanothione reductase | Inhibition | 25.0 | % | 10.1016/j.bmc.2008.05.074 |
| Trypanosoma cruzi | Trypanothione reductase | Inhibition | 45.0 | % | 10.1016/j.bmc.2008.05.074 |
| Trypanosoma cruzi | Trypanothione reductase | Inhibition | 73.0 | % | 10.1016/j.bmc.2008.05.074 |
| Trypanosoma cruzi | Trypanothione reductase | Inhibition | 91.0 | % | 10.1016/j.bmc.2008.05.074 |
| None | ADMET | Ratio | 14.4 | None | 10.1021/jm8003625 |
| None | ADMET | Ratio | 46.0 | None | 10.1021/jm8003625 |
| None | ADMET | Ratio | 95.4 | None | 10.1021/jm8003625 |
| None | ADMET | %Remaining | 60.0 | % | 10.1021/jm900480x |
| None | NON-PROTEIN TARGET | IC50 | 14600.0 | nM | 10.1016/j.bmcl.2005.03.021 |
| None | Unchecked | Ac50 | 3.548 | uM | None |
| None | Unchecked | Ac50 | 10.0 | uM | None |
| None | Unchecked | AC50 | 3548.1 | nM | None |
| None | Unchecked | AC50 | 10000.0 | nM | None |
| None | Unchecked | Activity | 84.0 | % | 10.1016/j.bmcl.2017.08.060 |
| None | Unchecked | Ki | 2.0 | nM | 10.1021/jm8003625 |
| None | Unchecked | Ki | 1905.46 | nM | 10.1021/jm8003625 |
| None | Unchecked | Ki | 10000.0 | nM | 10.1021/jm8003625 |
| None | Unchecked | Potency | 3162.3 | nM | None |
| None | Unchecked | Potency | 11220.2 | nM | None |
| None | Unchecked | Selectivity ratio | 1860.0 | None | 10.1021/jm8003625 |
